iPLEDGE REMS: US FDA Advisory Cmte. Supports Relaxing Restrictions But Wants More Data

 
• By Brenda Sandburg
  
Isotretinoin foil package
US FDA advisory committee recommends changes to iPLEDGE isotretinoin REMS program • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers